EP 2588103 A1 20130508 - A COMBINATION OF ATORVASTATIN AND ASPIRIN TO BE USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES
Title (en)
A COMBINATION OF ATORVASTATIN AND ASPIRIN TO BE USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES
Title (de)
KOMBINATION AUS ATORVASTATIN UND ASPIRIN ZUR BEHANDLUNG VON HERZ-KREISLAUF-ERKRANKUNGEN
Title (fr)
COMBINAISON D'ATORVASTATINE ET D'ASPIRINE DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DE MALADIES CARDIOVASCULAIRES
Publication
Application
Priority
- TR 201005325 A 20100630
- TR 2011000162 W 20110629
Abstract (en)
[origin: WO2012002919A1] The present invention relates to pharmaceutical compositions comprising aspirin and atorvastatin and/or pharmaceutically acceptable salts, hydrates, enantiomers, racemates, organic salts, inorganic salts, esters, polymorphs, crystal forms and amorphous forms thereof and/or their combinations in order to be used in the treatment and prophylaxis of cardiovascular diseases.
IPC 8 full level
A61K 31/40 (2006.01); A61K 9/28 (2006.01); A61K 31/60 (2006.01); A61P 3/06 (2006.01); A61P 9/10 (2006.01)
CPC (source: EP)
A61K 9/4808 (2013.01); A61K 9/5084 (2013.01); A61K 31/40 (2013.01); A61K 31/60 (2013.01); A61P 3/06 (2017.12); A61P 7/02 (2017.12); A61P 9/10 (2017.12)
Citation (search report)
See references of WO 2012011882A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012002919 A1 20120105; EP 2588102 A1 20130508; EP 2588103 A1 20130508; TR 201005325 A2 20120123; WO 2012002920 A1 20120105; WO 2012011882 A1 20120126
DOCDB simple family (application)
TR 2011000161 W 20110629; EP 11746335 A 20110629; EP 11764886 A 20110629; TR 201005325 A 20100630; TR 2011000162 W 20110629; TR 2011000163 W 20110629